Atopic Dermatitis Improvement Observed With Ruxolitinib Cream in Pediatric Trial

Positive topline results were announced from a phase 3 trial evaluating ruxolitinib cream in pediatric patients with atopic dermatitis.

Related Keywords

Jim Lee ,Group Vice ,Global Assessment Treatment Success ,Group Vice President ,